These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9048270)

  • 21. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
    van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
    Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.
    Compton P; Ling W; Moody D; Chiang N
    Drug Alcohol Depend; 2006 Mar; 82(1):25-31. PubMed ID: 16144748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
    Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder.
    Laffont CM; Gomeni R; Heidbreder C; Jones JP; Nasser AF
    J Clin Pharmacol; 2016 Jul; 56(7):806-15. PubMed ID: 26479717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.
    Strain EC; Stoller K; Walsh SL; Bigelow GE
    Psychopharmacology (Berl); 2000 Mar; 148(4):374-83. PubMed ID: 10928310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of low-dose and high-dose buprenorphine in cats after rectal administration of different formulations.
    Schroers M; Meyer-Lindenberg A; Reese S; Dobenecker B; Pieper K
    J Feline Med Surg; 2019 Oct; 21(10):938-943. PubMed ID: 30427272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits.
    Askar R; Fredriksson E; Manell E; Hedeland M; Bondesson U; Bate S; Olsén L; Hedenqvist P
    BMC Vet Res; 2020 Nov; 16(1):436. PubMed ID: 33176781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
    Fihlman M; Hemmilä T; Hagelberg NM; Kuusniemi K; Backman JT; Laitila J; Laine K; Neuvonen PJ; Olkkola KT; Saari TI
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1363-1371. PubMed ID: 27510521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block.
    McAleer SD; Mills RJ; Polack T; Hussain T; Rolan PE; Gibbs AD; Mullins FG; Hussein Z
    Drug Alcohol Depend; 2003 Oct; 72(1):75-83. PubMed ID: 14563545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
    Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine: new tricks with an old molecule for pain management.
    Heit HA; Gourlay DL
    Clin J Pain; 2008 Feb; 24(2):93-7. PubMed ID: 18209513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
    Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
    J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial.
    Ahmadi J; Jahromi MS; Ehsaei Z
    Trials; 2018 Aug; 19(1):462. PubMed ID: 30157924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I pharmacokinetic and bioavailability study of a sublingual fentanyl wafer in healthy volunteers.
    Lim CB; Schug SA; Sunderland VB; Paech MJ; Liu Y
    Anesth Analg; 2012 Sep; 115(3):554-9. PubMed ID: 22584544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
    Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
    Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.
    Chawarski MC; Moody DE; Pakes J; O'Connor PG; Schottenfeld RS
    J Subst Abuse Treat; 2005 Dec; 29(4):307-12. PubMed ID: 16311183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.